Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 86.27

+6.0%

Jan 7 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2508)	6/17/2010 12:11:24 PM
From: Jibacoa	1 Recommendation Read Replies (1) of 3722

XOMA is also among the Biotechs staying on the green today.<g> The stock was up 10.63% earlier and is still up 2.43% on good volume about half its ADV bigcharts.marketwatch.com XOMA has reported lower revenues in the last 2Qs. In the 1stQ revenues were significantly lower at 7.2M vs.39.7M and it reported a loss of $0.09 vs. a gain of $0.04 in 2009 The EL for this Yr. is around $0.20 vs. gain of $0.01 in 2009 The stock is been helped today after it announced that its potential treatment for uveitis of Behcet's disease met key goals in an early-stage study. Xoma 052 met goals of reducing swelling and improving visual activity in the seven-person study, and no drug-related adverse events were reported..<g> That drug is also being developed as a potential treatment for D.M. Back in October XOMA started a PII of XOMA 052 on patients with D.M. The ACTAY is $1.98 That would be a nice % gain from present levels.<g> It seems that the R/R isn't bad at present levels.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next